Related Experiment Videos
Interleukin 10 production by human melanoma
1Department of Medicine, Division of Neoplastic Diseases, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. t_sato@lac.jci.tju.edu
Summary
Metastatic melanoma tissues produce Interleukin 10 (IL-10) protein, a key immune-downregulating cytokine. This suggests melanoma cells may use IL-10 to evade immune responses.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Interleukin 10 (IL-10) is known to suppress cell-mediated immunity.
- Previous findings indicated the presence of IL-10 mRNA in metastatic melanoma tissues.
Purpose of the Study:
- To investigate whether melanoma metastases actively produce IL-10 protein.
- To identify the cellular source of IL-10 production within metastatic melanoma samples.
Main Methods:
- Enzymatic dissociation of melanoma metastases to create single-cell suspensions.
- Incubation of cells to measure IL-10 protein production via ELISA.
- Fractionation of cell suspensions using anti-CD45 antibody-conjugated magnetic beads to separate melanoma cells from leukocytes.
- Immunohistochemical staining of tissue sections and cytospin preparations.
Main Results:
- 30 out of 35 metastatic melanoma samples produced IL-10 protein in vitro.
- IL-10 production was primarily attributed to melanoma cells, not tumor-associated leukocytes.
- Elevated circulating IL-10 levels were observed in some patients with clinically evident metastases.
Conclusions:
- IL-10 production is a characteristic feature of metastatic melanomas.
- Melanoma-derived IL-10 may play a role in immune evasion or modulation of the anti-tumor immune response.
- Further research is warranted to explore the therapeutic implications of targeting IL-10 in melanoma treatment.